The Fred Hutchinson Cancer Center (Fred Hutch) and the University of Washington (UW) are jointly recruiting a full-time faculty member at the Associate or full Professor level without tenure due to funding (WOT) to serve as Scientific Director of the multiple myeloma program. The successful candidate will join the Translational Science and Therapeutics Division (TST) and the Immunotherapy Integrated Research Center (IIRC) of the Fred Hutch, and the Division of Medical Hematology and Oncology, Department of Medicine at the UW. The primary appointment will be with Fred Hutch. Academic appointment at the University of Washington will be commensurate with experience, qualifications, and academic rank. The position will allow for outpatient and/or inpatient clinical service. Associate and full Professors (WOT) hold indefinite appointments that align with a 12-month service period (July 1-June 30). Faculty with 12-month service periods are paid for 11 months of service over a 12-month period (July-June), meaning the equivalent of one month is available for paid time off. Fred Hutch and University of Washington faculty engage in teaching, research and service. This position is paid directly by Fred Hutchinson Cancer Center (Fred Hutch) and receives no UW compensation. Please refer to Fred Hutch for information about compensation for this position.

The selected individual for the advertised position will foster an environment of collaboration and productivity with clinicians and laboratory scientists in the multiple myeloma and cancer immunology programs. Teaching opportunities include oversight of advanced practice providers and fellows during inpatient and outpatient rotations, and delivery of informal teaching sessions and formal lectures to providers and the general medical community.

The successful candidate will enter a dynamic research environment with opportunities to collaborate with scientists across a diverse range of disciplines.

Fred Hutch is an independent, nonprofit organization providing adult cancer treatment and groundbreaking research focused on cancer and infectious diseases. Based in Seattle, Fred Hutch is the only National Cancer Institute-designated cancer center in Washington.

With a track record of global leadership in bone marrow transplantation, HIV/AIDS prevention, immunotherapy and COVID-19 vaccines, Fred Hutch has earned a reputation as one of the world’s leading cancer, infectious disease and biomedical research centers. Fred Hutch operates eight clinical care sites that provide medical oncology, infusion, radiation, proton therapy and related services, and network affiliations with hospitals in five states. Together, our fully integrated research and clinical care teams seek to discover new cures to the world’s deadliest diseases and make life beyond cancer a reality.

At Fred Hutch we value collaboration, compassion, determination, excellence, innovation, integrity and respect. These values are grounded in and expressed through the principles of diversity, equity and inclusion. Our mission is directly tied to the humanity, dignity and inherent value of each employee, patient, community member and supporter. Our commitment to learning across our differences and similarities make us stronger. We seek employees who bring different and innovative ways of seeing the world and solving problems. Fred Hutch is in pursuit of becoming an antiracist organization. We are committed to ensuring that all candidates hired share our commitment to diversity, antiracism, and inclusion.

Anticipated Start Date: July 1, 2024

The successful candidate must have expertise in multiple myeloma, a proven track record of leadership, and be engaged in laboratory-based research investigating the biology of multiple myeloma, adoptive cellular therapies and/or the regulation of immune responses in the tumor microenvironment or other factors that impact tumor progression or regression. Candidates must demonstrate a track record of peer-reviewed publications in the multiple myeloma field and success in obtaining extramural funding. Applicants must have a MD or MD/PhD degree, or foreign equivalent, board certification or eligibility in Medical Oncology (or foreign equivalent) and must be eligible for medical licensure in the state of Washington. In order to be eligible for University sponsorship for an H-1B visa, graduates of foreign (non-U.S.) medical schools must show successful completion of all three steps of the U.S. Medical Licensing Exam (USMLE) or equivalent as determined by the Secretary of Health and Human Services.  

Interested candidates should submit a curriculum vitae; a concise research plan (5-page limit); a diversity, equity, and inclusion statement describing your past contributions to diversity, equity, and inclusion and your future plans for continuing these efforts as a faculty member (two pages or less); and the names and contact information for five (5) professional references.